» Articles » PMID: 22130109

Independent Estimation of the Frequency of Rare CNVs in the UK Population Confirms Their Role in Schizophrenia

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2011 Dec 2
PMID 22130109
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several large, rare chromosomal copy number variants (CNVs) have recently been shown to increase risk for schizophrenia and other neuropsychiatric disorders including autism, ADHD, learning difficulties and epilepsy.

Aims: We wanted to examine the frequencies of these schizophrenia-associated variants in a large sample of individuals with non-psychiatric illnesses to better understand the robustness and specificity of the association with schizophrenia.

Methods: We used Affymetrix 500K microarray data from 10,259 individuals from the UK Wellcome Trust Case Control Consortium (WTCCC) who are affected with six non-psychiatric disorders (coronary artery disease, Crohn's disease, hypertension, rheumatoid arthritis, types 1 and 2 diabetes) to establish the frequencies of nine CNV loci strongly implicated in schizophrenia, and compared them with the previous findings.

Results: Deletions at 1q21.1, 3q29, 15q11.2, 15q13.1 and 22q11.2 (VCFS region), and duplications at 16p11.2 were found significantly more often in schizophrenia cases, compared with the WTCCC reference set. Deletions at 17p12 and 17q12, were also more common in schizophrenia cases but not significantly so, while duplications at 16p13.1 were found at nearly the same rate as in previous schizophrenia samples. The frequencies of CNVs in the WTCCC non-psychiatric controls at three of the loci (15q11.2, 16p13.1 and 17p12) were significantly higher than those reported in previous control populations.

Conclusions: The evidence for association with schizophrenia is compelling for six rare CNV loci, while the remaining three require further replication in large studies. Risk at these loci extends to other neurodevelopmental disorders but their involvement in common non-psychiatric disorders should also be investigated.

Citing Articles

Association of neurotransmitter pathway polygenic risk with specific symptom profiles in psychosis.

Warren T, Tubbs J, Lesh T, Corona M, Pakzad S, Albuquerque M Mol Psychiatry. 2024; 29(8):2389-2398.

PMID: 38491343 PMC: 11412910. DOI: 10.1038/s41380-024-02457-0.


Loss of Function in the Neurodevelopmental Disease and Schizophrenia-Associated Gene CYFIP1 in Human Microglia-like Cells Supports a Functional Role in Synaptic Engulfment.

Sheridan S, Horng J, Yeh H, McCrea L, Wang J, Fu T Biol Psychiatry. 2023; 95(7):676-686.

PMID: 37573007 PMC: 10874584. DOI: 10.1016/j.biopsych.2023.07.022.


Association of neurotransmitter pathway polygenic risk with specific symptom profiles in psychosis.

Warren T, Tubbs J, Lesh T, Corona M, Pakzad S, Albuquerque M medRxiv. 2023; .

PMID: 37292649 PMC: 10246134. DOI: 10.1101/2023.05.24.23290465.


FMRP and CYFIP1 at the Synapse and Their Role in Psychiatric Vulnerability.

Clifton N, Thomas K, Wilkinson L, Hall J, Trent S Complex Psychiatry. 2021; 6(1-2):5-19.

PMID: 34883502 PMC: 7673588. DOI: 10.1159/000506858.


An ethical analysis of divergent clinical approaches to the application of genetic testing for autism and schizophrenia.

Morris E, ODonovan M, Virani A, Austin J Hum Genet. 2021; 141(5):1069-1084.

PMID: 34453583 DOI: 10.1007/s00439-021-02349-1.


References
1.
Christiansen J, Dyck J, Elyas B, Lilley M, Bamforth J, Hicks M . Chromosome 1q21.1 contiguous gene deletion is associated with congenital heart disease. Circ Res. 2004; 94(11):1429-35. DOI: 10.1161/01.RES.0000130528.72330.5c. View

2.
Price T, Regan R, Mott R, Hedman A, Honey B, Daniels R . SW-ARRAY: a dynamic programming solution for the identification of copy-number changes in genomic DNA using array comparative genome hybridization data. Nucleic Acids Res. 2005; 33(11):3455-64. PMC: 1151590. DOI: 10.1093/nar/gki643. View

3.
Bingham C, Hattersley A . Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1beta. Nephrol Dial Transplant. 2004; 19(11):2703-8. DOI: 10.1093/ndt/gfh348. View

4.
Chance P, Alderson M, Leppig K, Lensch M, Matsunami N, Smith B . DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 1993; 72(1):143-51. DOI: 10.1016/0092-8674(93)90058-x. View

5.
Wang K, Li M, Hadley D, Liu R, Glessner J, Grant S . PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 2007; 17(11):1665-74. PMC: 2045149. DOI: 10.1101/gr.6861907. View